Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:TEM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeTEMTempus AI$46.66+0.4%$49.02$41.73▼$104.32$8.38B3.995.59 million shs2.35 million shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceTEMTempus AI+1.33%+2.22%-15.70%-20.35%-20.04%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeTEMTempus AI$46.66+0.4%$49.02$41.73▼$104.32$8.38B3.995.59 million shs2.35 million shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceTEMTempus AI+1.33%+2.22%-15.70%-20.35%-20.04%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceTEMTempus AI 2.50Moderate Buy$68.6448.88% UpsideCurrent Analyst Ratings BreakdownLatest FGT, EMG, RCP, and TEM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/11/2026TEMTempus AI HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$95.00 ➝ $64.005/8/2026TEMTempus AI BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$90.00 ➝ $80.005/6/2026TEMTempus AI TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$65.00 ➝ $68.004/13/2026TEMTempus AI TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Buy$65.004/13/2026TEMTempus AI Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageUnderperform$35.003/30/2026TEMTempus AI GuggenheimSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$95.00 ➝ $60.003/11/2026TEMTempus AI Needham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$75.003/9/2026TEMTempus AI HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$89.00 ➝ $95.003/3/2026TEMTempus AI Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$85.00 ➝ $70.002/25/2026TEMTempus AI Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$60.00(Data available from 5/22/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookTEMTempus AI$1.36B6.07N/AN/A$2.32 per share19.87Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateTEMTempus AI-$245.03M-$1.72N/AN/AN/A-22.20%-53.83%-11.17%N/ALatest FGT, EMG, RCP, and TEM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/5/2026Q1 2026TEMTempus AI-$0.21-$0.13+$0.08-$0.71$345.44 million$348.12 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthTEMTempus AIN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioTEMTempus AI2.963.313.15Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipTEMTempus AI24.22%Insider OwnershipCompanyInsider OwnershipTEMTempus AI24.26%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableTEMTempus AI3,800179.57 million136.00 millionN/AGSCT, RCP, TEM, and CTY HeadlinesRecent News About These CompaniesTempus AI: Taking Advantage Of Investor Myopia2 hours ago | seekingalpha.comTempus AI (NASDAQ:TEM) CAO Sells $181,392.12 in Stock4 hours ago | insidertrades.com5 Best ARK Stocks to Buy Right NowMay 21 at 7:50 PM | insidermonkey.comTempus AI Expands Cancer Platform With Launch of ArteraAI Prostate Test For Metastatic PatientsMay 21 at 5:56 PM | finance.yahoo.comTempus Launches ArteraAI Prostate Test for Metastatic Patients, Marking the First Prostate Digital Pathology Algorithm in the Tempus Ecosystem Available for Clinical UseMay 21 at 8:30 AM | businesswire.com4 Heavily Shorted AI Stocks to Watch Right NowMay 20 at 3:13 PM | schaeffersresearch.comAssessing Tempus AI (TEM) Valuation After Recent Share Price WeaknessMay 19 at 6:00 PM | finance.yahoo.comHow beaten-down Tempus AI stock offers a lottery ticket for traders hereMay 18, 2026 | msn.comTempus AI And BMS Deepen AI Drug Development Ties As Losses PersistMay 18, 2026 | finance.yahoo.com7 Healthcare AI Stocks Under $50 With Huge Upside PotentialMay 18, 2026 | 247wallst.comTempus AI, Inc. (NASDAQ:TEM) Receives Consensus Rating of "Moderate Buy" from BrokeragesMay 15, 2026 | americanbankingnews.comTempus AI, Inc. (NASDAQ:TEM) Receives Consensus Recommendation of "Moderate Buy" from AnalystsMay 15, 2026 | marketbeat.comHere’s Why Aristotle Core Equity Fund Bets on Tempus AI (TEM), a Healthcare Technology CompanyMay 14, 2026 | insidermonkey.comTempus AI Completes Convertible Notes Offering, Retires Secured DebtMay 13, 2026 | tipranks.comBTIG Sticks to Their Buy Rating for Tempus AI, Inc. Class A (TEM)May 12, 2026 | theglobeandmail.comIs Tempus AI (TEM) The Best AI Healthcare Stock to Buy?May 10, 2026 | finance.yahoo.comCathie Wood invests $14.9M in Tempus AI after earnings beatMay 10, 2026 | msn.comTempus AI Expands Beyond Oncology With New Alzheimer’s Blood Test AllianceMay 10, 2026 | finance.yahoo.comCathie Wood buys $14.9 million of Tempus AI stockMay 8, 2026 | msn.comTempus AI (NASDAQ:TEM) Price Target Cut to $80.00 by Analysts at BTIG ResearchMay 8, 2026 | marketbeat.comTempus AI: My Pick For An Oncoming Boom In Demand For Data-Driven Precision MedicineMay 8, 2026 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSTMicronelectronics Sends Industrial Chips Into OverdriveBy Thomas Hughes | April 24, 2026Beyond NVIDIA: Picks-and-Shovels AI Plays with Strong MomentumBy Chris Markoch | May 10, 2026How the 3 Leading Quantum Firms Stack Up After Q1 EarningsBy Nathan Reiff | May 14, 2026Years in the Making, AMD’s Upside Movement Has Just BegunBy Thomas Hughes | May 6, 2026Rocket Lab Posts Record Q1 Revenue, Raises Q2 GuidanceBy Ryan Hasson | May 8, 2026GSCT, RCP, TEM, and CTY Company DescriptionsTempus AI NASDAQ:TEM$46.66 +0.17 (+0.37%) As of 12:52 PM Eastern This is a fair market value price provided by Massive. Learn more.Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending Intuit's Great SaaS Reset: Fired By AI Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish Target Shows Strengths, But Analysts Want to See More Lowe's Finds Support at $215 After Q1 Earnings Sell-Off Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
